Skip to main content

Table 2 Descriptive statistics of extracted unit cost and utilization outcomes in high income (Belgium, Denmark, France, Germany, Netherlands, Norway, Spain, Sweden, Switzerland and UK) and low- and middle-income (Czechia, Greece, Hungary, Italy, Poland and Romania) countries

From: Economic burden of varicella in Europe in the absence of universal varicella vaccination

Unit parameter Median Min Max
a. High income countries
 Cost of physician visit (EUR) 325.08 4.52 [29] 72.41 [22]
 Cost of 1 day hospitalization (EUR) 554.36 128.85 [24] 1304.44 [9]
 Length of hospitalization (days) 4.85 1.7 [67] 9 [43]
 Cost of OTC medications (EUR) 14.34 2.05 [24] 15.86 [18]
 Utilization OTC medicationsa (%) 100 100 [24] 100 [24]
 Cost of prescribed medications (EUR) 15.16 2.8 [35] 25.77 [23]
 Utilization of prescribed medications (%) 70.3 47.7 [82] 100 [8]
 Work lost by caregiverb (days) 1.42 0.3] [70] 6.6 [57]
 Work lost by patientb (days) 8.1 1.44 [18] 18.72 [5]
b. Low- and middle-income countries
 Cost of physician visit (EUR) 29.02 9.55 [30] 52.29 [34]
 Cost of 1 day hospitalization (EUR) 155.35 97.03 [30] 629 [32]
 Length of hospitalization (days) 5.89 3.6 [30] 7.9 [68]
 Cost of OTC medications (EUR) 0.55 0.4 [30] 4.84 [32]
 Utilization of OTC medicationsa (%) 96 80 [34] 100 [32]
 Cost of prescribed medications (EUR) 21.39 9.4 [34] 31.57 [30]
 Utilization of prescribed medications (%) 72 9.3 [30] 100 [32]
 Work lost by caregiverb (days) 2.61 0.6 [31] 4.98 [78]
 Work lost by patientb (days) 6.8 2.6 [49] 11 [31]
  1. a available for 4 countries; despite the fact that the parameter was available for less than 5 countries (cf. selection criterion), it was decided to include it in the cost model because the associated parameter, cost of OTC medications, was already included
  2. b for outpatient cases